Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Awaiting development
Guidance and quality standards
Awaiting development
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (4 active)
Skip to results
Filter by title or keyword
Filter
Type
(
3 selected
)
Type
Guidance (8)
NICE advice (0)
Quality standard (2)
Guidance programme
Guidance programme
Technology appraisal guidance (8)
Apply filters
Showing 1 to 10 of 10
child* or youth or infant
Remove child* or youth or infant filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Type: NICE advice
Remove Type: NICE advice filter
Guidance and quality standards awaiting development
Title
Type
Children
and young people with disabilities and severe complex needs: integrated health and social care support
Quality standard
Dupilumab for treating eosinophilic oesophagitis in
children
1 to 11 years TS ID 11885
Technology appraisal guidance
Evinacumab for treating homozygous familial hypercholesterolemia in
children
aged 5 to 11 TS ID 11806
Technology appraisal guidance
Infant
,
children
and young people's experience of health care
Quality standard
Odevixibat for treating biliary atresia in
children
following Kasai hepatoportoenterostomy TSID 11996
Technology appraisal guidance
Perampanel for adjunctive treatment of partial onset or generalised tonic-clonic seizures in
children
aged below 12 years with epilepsy ID1587
Technology appraisal guidance
Setmelanotide for treating obesity caused by a rare genetic disorder in
children
aged 2 to 5 TS ID 11827
Technology appraisal guidance
Tideglusib for treating congenital or
childhood
onset myotonic dystrophy [ID3915 ]
Technology appraisal guidance
Vosoritide for treating achondroplasia in
children
TSID 12001
Technology appraisal guidance
Vosoritide for treating achondroplasia in
children
and young people under 18 years [ID3807]
Technology appraisal guidance
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top